Cancer Biopsy Market to Reach US$ 54.7 Billion by 2033, Registering 9.8% CAGR
Precision Diagnostics and Liquid Biopsy Innovation Drive Strategic Shifts in Global Cancer Biopsy Market
Global **Cancer Biopsy Market Overview
The global cancer biopsy market is positioned at a pivotal juncture, with a projected expansion from US$ 28.4 billion in 2026 to US$ 54.7 billion by 2033, according to Market Minds Advisory. This growth trajectory reflects the sector’s increasing integration within precision oncology, as healthcare systems prioritize early detection and minimally invasive diagnostic solutions. Core technologies such as liquid biopsy, next-generation sequencing (NGS), and digital pathology are rapidly advancing, enabling more accurate tumor profiling and real-time disease monitoring.
Regulatory agencies are facilitating market evolution through expedited approvals for innovative biopsy platforms and companion diagnostics. Structural transformation is further driven by the convergence of molecular diagnostics and artificial intelligence, which is enhancing both workflow efficiency and clinical decision-making.
ZPayNG
Business
I Videos Play Videos
Instant Go
Appvertor